Evidence map›Paper›PMID 24889093›Full record

ArticleProteins2014

Structure-based simulations reveal concerted dynamics of GPCR activation.

Nicholas Leioatts, Pooja Suresh, Tod D Romo, Alan Grossfield

Abstract readComparative Study
In one paragraph

Article in Proteins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The World of GPCR dimers - Mapping dopamine receptor DComputational and structural biotechnology journal · 2023
    Article
  2. Article
  3. Investigation of the conformational dynamics of the apo A2A adenosine receptor.Protein science : a publication of the Protein Society · 2015
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicholas LeioattsDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, 14642.
Pooja Suresh
Tod D Romo
Alan Grossfield

Funding

Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Multiscale modeling of G protein-coupled receptorsR01GM095496 · NIGMS · UNIVERSITY OF ROCHESTER · PI GROSSFIELD, ALAN · 2011 to 2015
$1.3M
NIGMS NIH HHS GM068411NIGMS NIH HHS GM095496NIGMS NIH HHS R01 GM095496NIGMS NIH HHS T32 GM068411
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are a vital class of proteins that transduce biological signals across the cell membrane. However, their allosteric activation mechanism is not fully understood; crystal structures of active and inactive receptors have been reported, but the functional pathway between these two states remains elusive. Here, we use structure-based (Gō-like) models to simulate activation of two GPCRs, rhodopsin and the β₂ adrenergic receptor (β₂AR). We used data-derived reaction coordinates that capture the activation mechanism for both proteins, showing that activation proceeds through quantitatively different paths in the two systems. Both reaction coordinates are determined from the dominant concerted motions in the simulations so the technique is broadly applicable. There were two surprising results. First, the main structural changes in the simulations were distributed throughout the transmembrane bundle, and not localized to the obvious areas of interest, such as the intracellular portion of Helix 6. Second, the activation (and deactivation) paths were distinctly nonmonotonic, populating states that were not simply interpolations between the inactive and active structures. These transitions also suggest a functional explanation for β₂AR's basal activity: it can proceed through a more broadly defined path during the observed transitions.

Indexed as

Models, MolecularAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsAllosteric RegulationAmino Acid SequenceAnimalsCattleConserved SequenceDatabases, ProteinDrug Inverse AgonismHumansLigandsLipid BilayersMolecular Dynamics SimulationPrincipal Component AnalysisProtein ConformationADRB2 protein, humanAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AntagonistsLigandsLipid BilayersmetarhodopsinsReceptors, Adrenergic, beta-2Recombinant ProteinsRhodopsinadrenergic receptorG protein-coupled receptorsrhodopsinsignal transductionstructural transitions

Identifiers

PMID24889093
PMCPMC4177312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.